Intellipharmaceutics International Inc. (IPCIF)
USD 0.15
(50.0%)
USD 0.15
(50.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2019 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 65.72 Thousand | 65.72 Thousand | 1.4 Million | 1.4 Million | 1.71 Million | 5.5 Million |
| Cost of Revenue | - | 256.45 Thousand | 430.93 Thousand | 33.06 Thousand | 124.87 Thousand | 704 Thousand |
| Gross Profit | 65.72 Thousand | -190.72 Thousand | 970.58 Thousand | 1.36 Million | 1.58 Million | 4.8 Million |
| Operating Expenses | 2.91 Million | 2.91 Million | 4.17 Million | 6.07 Million | 14.91 Million | 13.06 Million |
| Selling, General and Administrative Expenses | 561.05 Thousand | 561.05 Thousand | 1.24 Million | 2.14 Million | 3.47 Million | 3.28 Million |
| Research and Development Expenses | 2.14 Million | 2.14 Million | 2.66 Million | 3.51 Million | 10.82 Million | 9.27 Million |
| Other Expenses | - | 206.05 Thousand | 261.52 Thousand | 415.37 Thousand | 610.38 Thousand | 506.96 Thousand |
| Cost and Expenses | 2.91 Million | 2.91 Million | 4.17 Million | 6.07 Million | 15.03 Million | 13.77 Million |
| Operating Income | -2.85 Million | -2.85 Million | -4.17 Million | -4.67 Million | -13.32 Million | -8.26 Million |
| Interest Expense | 291.61 Thousand | 291.61 Thousand | 549.29 Thousand | 969.65 Thousand | 255.23 Thousand | 526.6 Thousand |
| Income Tax Expense | 5337.00 | 5337.00 | -114.18 Thousand | 32.83 Thousand | -8592.00 | 80.09 Thousand |
| Earnings before Tax | -2.88 Million | -2.88 Million | -5.25 Million | -3.35 Million | -13.74 Million | -8.85 Million |
| Net Income | -2.89 Million | -2.89 Million | -5.14 Million | -3.39 Million | -13.73 Million | -8.93 Million |
| Earnings Per Share Basic | -0.09 | -0.10 | -0.22 | -0.16 | -2.88 | -2.88 |
| Earnings Per Share Diluted | -0.09 | -0.10 | -0.22 | -0.16 | -2.88 | -2.88 |
| Weighted Average Shares Outstanding | 33.09 Million | 29.43 Million | 23.56 Million | 21.58 Million | 4.76 Million | 3.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.09 Million | 29.43 Million | 23.56 Million | 21.58 Million | 4.76 Million | 3.1 Million |
| Gross Margin | 1.00 | -2.90 | 0.69 | 0.98 | 0.93 | 0.87 |
| EBIT Margin | -40.23 | -40.23 | -2.79 | -1.26 | -7.52 | -1.40 |
| Profit Margin | -44.01 | -44.01 | -3.67 | -2.42 | -8.02 | -1.62 |
| EBITDA | -2.64 Million | -2.64 Million | -3.91 Million | -1.76 Million | -12.88 Million | -7.72 Million |
| Earnings Before Tax Margin | -43.37 | -43.37 | -2.98 | -3.34 | -7.78 | -1.50 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 68.71 Thousand | 480.2 Thousand | 326.34 Thousand | 29.68 Thousand | 65.72 Thousand | 19.06 Thousand |
| Cost of Revenue | 873.71 Thousand | 33.83 Thousand | 51.5 Thousand | - | - | - |
| Gross Profit | -805 Thousand | 446.36 Thousand | 274.84 Thousand | 29.68 Thousand | 65.72 Thousand | 19.06 Thousand |
| Operating Expenses | 982.37 Thousand | 511.55 Thousand | 627.74 Thousand | 489.26 Thousand | 2.91 Million | 385.25 Thousand |
| Selling, General and Administrative Expenses | 193.52 Thousand | 93.5 Thousand | 138.83 Thousand | 348.98 Thousand | - | -292.29 Thousand |
| Research and Development Expenses | 748.21 Thousand | 377.5 Thousand | 448.16 Thousand | 88.64 Thousand | - | 626.06 Thousand |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 1.85 Million | 511.55 Thousand | 627.74 Thousand | 489.26 Thousand | 2.91 Million | 385.25 Thousand |
| Operating Income | -1.78 Million | -31.35 Thousand | -301.4 Thousand | -459.57 Thousand | -2.85 Million | -366.18 Thousand |
| Interest Expense | 66.89 Thousand | 51.88 Thousand | 50.76 Thousand | 64.55 Thousand | 291.61 Thousand | 53.03 Thousand |
| Income Tax Expense | 66.89 Thousand | 51.88 Thousand | 50.76 Thousand | 69.89 Thousand | 5337.00 | 53.03 Thousand |
| Earnings before Tax | -1.88 Million | -54.12 Thousand | -355.73 Thousand | -869.38 Thousand | -2.88 Million | -296.04 Thousand |
| Net Income | -1.88 Million | -54.12 Thousand | -355.73 Thousand | -874.72 Thousand | -2.89 Million | -296.04 Thousand |
| Earnings Per Share Basic | -0.06 | -0.00 | -0.01 | -0.03 | - | -0.01 |
| Earnings Per Share Diluted | -0.06 | -0.00 | -0.01 | -0.03 | - | -0.01 |
| Weighted Average Shares Outstanding | 33.09 Million | 33.09 Million | 33.09 Million | 33.09 Million | 33.09 Million | 33.09 Million |
| Weighted Average Shares Outstanding (Diluted) | 33.09 Million | 33.09 Million | 33.09 Million | 33.09 Million | 33.09 Million | 33.09 Million |
| Gross Margin | -11.71 | 0.93 | 0.84 | 1.00 | 1.00 | 1.00 |
| EBIT Margin | -25.42 | 0.02 | -0.80 | -13.74 | - | -16.50 |
| Profit Margin | -27.49 | -0.11 | -1.09 | -29.47 | -44.01 | -15.53 |
| EBITDA | -1.74 Million | 9192.00 | -260.65 Thousand | -407.95 Thousand | - | -314.7 Thousand |
| Earnings Before Tax Margin | -26.01 | -0.07 | -0.92 | -15.48 | -43.37 | -19.20 |
6363
MQY
AQUA
PETWW
MKL
011170